Omeros Corp. (OMER)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$18.95-0.84%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · OMER
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(10.3) + peer(0.2*6.7) + term(0.0) → 4.92% (capped ±15.0)
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On August 12, 2026, Omeros Corporation issued a press release announcing financial results for the three and six months ended June 30, 2026. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or oth…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On May 13, 2026, Omeros Corporation issued a press release announcing financial results for the three months ended March 31, 2026. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise sub…
Results of Operations and Financial Condition. On March 31, 2026, Omeros Corporation issued a press release announcing financial results for the three and twelve months ended December 31, 2025. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended,…
of Form 8-K, this filing is being made to report that at December 31, 2025, we had approximately $171.5 million of cash and short-term investments available for operations. This figure is preliminary and unaudited. It is subject to completion of the Company’s customary financial closing procedures and adjustments. The information in this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subj…
Results of Operations and Financial Condition. On November 13, 2025, Omeros Corporation issued a press release announcing financial results for the three and nine months ended September 30, 2025. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended…
Results of Operations and Financial Condition. On August 14, 2025, Omeros Corporation issued a press release announcing financial results for the three and six months ended June 30, 2025. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or oth…
Results of Operations and Financial Condition. On March 31, 2025, Omeros Corporation issued a press release announcing financial results for the three months and year ended December 31, 2024. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or…
Results of Operations and Financial Condition. On November 13, 2024, Omeros Corporation issued a press release announcing financial results for the three and nine months ended September 30, 2024. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended…
Results of Operations and Financial Condition. On August 7, 2024, Omeros Corporation issued a press release announcing financial results for the three and six months ended June 30, 2024. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or othe…
Results of Operations and Financial Condition. On May 15, 2024, Omeros Corporation issued a press release announcing financial results for the three months ended March 31, 2024. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise sub…
Results of Operations and Financial Condition. On April 1, 2024, Omeros Corporation issued a press release announcing financial results for the three months and year ended December 31, 2023. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or…
Results of Operations and Financial Condition. On November 9, 2023, Omeros Corporation issued a press release announcing financial results for the three and nine months ended September 30, 2023. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended,…
Results of Operations and Financial Condition. On May 9, 2023, Omeros Corporation issued a press release announcing financial results for the three and six months ended June 30, 2023. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwi…
Results of Operations and Financial Condition. On May 9, 2023, Omeros Corporation issued a press release announcing financial results for the three months ended March 31, 2023. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subj…
Results of Operations and Financial Condition. On March 13, 2023, Omeros Corporation issued a press release announcing financial results for the three months and year ended December 31, 2022. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or…
Results of Operations and Financial Condition. On February 6, 2023, Omeros Corporation (the “Company”) issued a press release announcing the receipt from Rayner Surgical, Inc. of a $200 million milestone payment due under the Asset Purchase Agreement, dated December 1, 2021, among the Company, Rayner Surgical Inc. and Rayner Surgical Group Limited . The press release also includes in its fourth and fifth paragraphs disclosure regarding 2022 U.S. net sales of OMIDRIA ® and the Company’s cash,…